Systemic sclerosis at the crossroad of polyautoimmunity

Autoimmunity Reviews

Volumn 12, Issue 11, 2013, Pages 1052-1057

  Elhai, Muriel ^a,b   Avouac, JerÔme ^a,b   Kahan, André ^a   Allanore, Yannick ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT COCHIN   (France)

Author keywords

Autoimmunity; Connective tissue diseases; Overlap; Systemic autoimmune disease; Systemic sclerosis

Indexed keywords

CENTROMERE ANTIBODY;

AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; DERMATOMYOSITIS; DISEASE ASSOCIATION; HUMAN; PHENOTYPE; POLYMYOSITIS; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; RACE DIFFERENCE; RECURRENT DISEASE; REVIEW; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SJOEGREN SYNDROME; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

AUTOIMMUNITY; CONNECTIVE TISSUE DISEASES; OVERLAP; SYSTEMIC AUTOIMMUNE DISEASE; SYSTEMIC SCLEROSIS;

AUTOIMMUNE DISEASES; COHORT STUDIES; HUMANS; PHENOTYPE; PREVALENCE; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME;

EID: 84881546490     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.05.002     Document Type: Review

References (58)

1. Allanore Y., Avouac J., Kahan A. Systemic sclerosis: an update in 2008. Joint Bone Spine 2008, 75:650-655.
2. Rossi D., Russo A., Manna E., Binello G., Baldovino S., Sciascia S., et al. The role of nail-videocapillaroscopy in early diagnosis of scleroderma. Autoimmun Rev 2013, 12:821-825.
3. Martin P., Teodoro W.R., Velosa A.P., de Morais J., Carrasco S., Christmann R.B., et al. Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis. Autoimmun Rev 2012, 11:827-835.
4. Allanore Y., Dieude P., Boileau C. Genetic background of systemic sclerosis: autoimmune genes take centre stage. Rheumatology (Oxford) 2010, 49:203-210.
5. Villalta D., Imbastaro T., Di Giovanni S., Lauriti C., Gabini M., Turi M.C., et al. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis. Autoimmun Rev 2012, 12:114-120.
6. Mehra S., Walker J., Patterson K., Fritzler M.J. Autoantibodies in systemic sclerosis. Autoimmun Rev 2013, 12:340-354.
7. Dieudé P., Boileau C., Allanore Y. Immunogenetics of systemic sclerosis. Autoimmun Rev 2011, 10:282-290.
8. Hudson M., Rojas-Villarraga A., Coral-Alvarado P., López-Guzmán S., Mantilla R.D., Chalem P., et al. Polyautoimmunity and familial autoimmunity in systemic sclerosis. J Autoimmun 2008, 31:156-159.
9. Becker K.G. The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses 2004, 62:309-317.
10. Avouac J., Airò P., Dieude P., Caramaschi P., Tiev K., Diot E., et al. Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients. J Rheumatol 2010, 37:608-614.
11. Antonelli A., Ferri C., Fallahi P., Cazzato M., Ferrari S.M., Sebastiani M., et al. Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. Eur J Endocrinol 2007, 156:431-437.
12. Hudson M., Pope J., Mahler M., Tatibouet S., Steele R., Baron M., et al. Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis. Arthritis Res Ther 2012, 14:R50.
13. Simeón-Aznar C.P., Fonollosa-Plá V., Tolosa-Vilella C., Espinosa-Garriga G., Ramos-Casals M., Campillo-Grau M., et al. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. Semin Arthritis Rheum 2012, 41:789-800.
14. Cavazzana I., Ceribelli A., Taraborelli M., Fredi M., Norman G., Tincani A., et al. Primary biliary cirrhosis-related autoantibodies in a large cohort of Italian patients with systemic sclerosis. J Rheumatol 2011, 38:2180-2185.
15. Hashimoto A., Endo H., Kondo H., Hirohata S. Clinical features of 405 Japanese patients with systemic sclerosis. Mod Rheumatol 2012, 22:272-279.
16. Pakozdi A., Nihtyanova S., Moinzadeh P., Ong V.H., Black C.M., Denton C.P. Clinical and serological hallmarks of systemic sclerosis overlap syndromes. J Rheumatol 2011, 38:2406-2409.
17. Balbir-Gurman A., Braun-Moscovici Y. Scleroderma overlap syndrome. Isr Med Assoc J 2011, 13:14-20.
18. Meyer O.C., Fertig N., Lucas M., Somogyi N., Medsger T.A. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol 2007, 34:104-109.
19. Biró E., Szekanecz Z., Czirják L., Dankó K., Kiss E., Szabó N.A., et al. Association of systemic and thyroid autoimmune diseases. Clin Rheumatol 2006, 25:240-245.
20. Caramaschi P., Biasi D., Volpe A., Carletto A., Cecchetto M., Bambara L.M. Coexistence of systemic sclerosis with other autoimmune diseases. Rheumatol Int 2007, 27:407-410.
21. Koumakis E., Dieudé P., Avouac J., Kahan A., Allanore Y. Association des Sclérodermiques de France. Familial autoimmunity in systemic sclerosis - results of a French-based case-control family study. J Rheumatol 2012, 39:532-538.
22. SimicPasalic K., Damjanov N., Marinkovic G. Associations of systemic sclerosis and other autoimmune diseases (analysis of 153 patients from a single EUSTAR centre) 2012, EULAR.
23. Assassi S., Fritzler M.J., Arnett F.C., Norman G.L., Shah K.R., Gourh P., et al. Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol 2009, 36:2250-2256.
24. Jacobsen S., Halberg P., Ullman S., Van Venrooij W.J., Høier-Madsen M., Wiik A., et al. Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br J Rheumatol 1998, 37:39-45.
25. Imura-Kumada S., Hasegawa M., Matsushita T., Hamaguchi Y., Encabo S., Shums Z., et al. High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis. Mod Rheumatol 2012, 22:892-898.
26. Ueda-Hayakawa I., Hasegawa M., Kumada S., Tanaka C., Komura K., Hamaguchi Y., et al. Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis. Rheumatology (Oxford) 2010, 49:2135-2139.
27. Szücs G., Szekanecz Z., Zilahi E., Kapitány A., Baráth S., Szamosi S., et al. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity. Rheumatology (Oxford) 2007, 46:989-993.
28. Jinnin M., Ihn H., Yamane K., Asano Y., Yazawa N., Tamaki K. Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritis. Clin Exp Rheumatol 2003, 21:91-94.
29. Kobak S., Oksel F., Aksu K., Kabasakal Y. The frequency of sicca symptoms and Sjögren's syndrome in patients with systemic sclerosis. Int J Rheum Dis 2013, 16:88-92.
30. Marrone M., Chialà A., Tampoia M., Iannone F., Raho L., Covelli M., et al. Prevalence of anti-CCP antibodies in systemic sclerosis. Reumatismo 2007, 59:20-24.
31. Davies T.F., Latif R., Yin X. New genetic insights from autoimmune thyroid disease. J Thyroid Res 2012, 2012:623852.
32. Koumakis E., Giraud M., Dieudé P., Cohignac V., Cuomo G., Airò P., et al. Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity. Arthritis Rheum 2012, 64:2746-2752.
33. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
34. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Committee: preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23:581-590.
35. LeRoy E.C., Medsger T.A. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001, 28:1573-1576.
36. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
37. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.
38. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
39. Bohan A., Peter J.B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975, 292:344-347.
40. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol 2009, 51:237-267.
41. Leuschner U. Primary biliary cirrhosis-presentation and diagnosis. Clin Liver Dis 2003, 7:741-758.
42. Sasaki H., Inoue K., Higuchi K., Yasuyama T., Koyata H., Kuroki T., et al. Primary biliary cirrhosis in Japan: national survey by the subcommittee on autoimmune hepatitis. Gastroenterol Jpn 1985, 20:476-485.
43. Inoue K., Hirohara J., Nakano T., Seki T., Sasaki H., Higuchi K., et al. Prediction of prognosis of primary biliary cirrhosis in Japan. Liver 1995, 15:70-77.
44. Pearce E.N., Farwell A.P., Braverman L.E. Thyroiditis. N Engl J Med 2003, 348:2646-2655.
45. Rojas-Villarraga A., Amaya-Amaya J., Rodriguez-Rodriguez A., Mantilla R.D., Anaya J.M. Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmun. Dis. 2012, 2012:254319.
46. Cardenas-Roldan J., Rojas-Villarraga A., Anaya J.M. How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med 2013, 11:73. [Epub ahead of print].
47. Watt F.E., James O.F., Jones D.E. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM 2004, 97:397-406.
48. Marasini B., Gagetta M., Rossi V., Ferrari P. Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients. Ann Rheum Dis 2001, 60:1046-1049.
49. Lazarus M.N., Isenberg D.A. Development of additional autoimmune diseases in a population of patients with primary Sjögren's syndrome. Ann Rheum Dis 2005, 64:1062-1064.
50. Culp K.S., Fleming C.R., Duffy J., Baldus W.P., Dickson E.R. Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 1982, 57:365-370.
51. Theander E., Jacobsson L.T. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am 2008, 34:935-947. [viii-ix].
52. McDonagh J.E., Isenberg D.A. Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann Rheum Dis 2000, 59:230-232.
53. Fenoglio D., Bernuzzi F., Battaglia F., Parodi A., Kalli F., Negrini S., et al. Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases. Autoimmun Rev 2012, 12:300-304.
54. Anaya J.M. The autoimmune tautology. Arthritis Res Ther 2010, 12:147.
55. Costenbader K.H., Gay S., Alarcón-Riquelme M.E., Iaccarino L., Doria A. Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?. Autoimmun Rev 2012, 11:604-609.
56. Antico A., Tampoia M., Tozzoli R., Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 2012, 12:127-136.
57. Rigamonti C., Shand L.M., Feudjo M., Bunn C.C., Black C.M., Denton C.P., et al. Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. Gut 2006, 55:388-394.
58. Iaccarino L., Gatto M., Bettio S., Caso F., Rampudda M., Zen M., et al. Overlap connective tissue disease syndromes. Autoimmun Rev 2013, 12:363-373.